Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 1—January 2023
Research

Risk for Severe COVID-19 Outcomes among Persons with Intellectual Disabilities, the Netherlands

Monique C.J. Koks-LeensenComments to Author , Bianca W.M. Schalk, Esther J. Bakker-van Gijssel, Aura Timen, Masha E. Nägele, Milou van den Bemd, Geraline L. Leusink, Maarten Cuypers, and Jenneken Naaldenberg
Author affiliations: Radboud Institute for Health Sciences, Nijmegen, the Netherlands (M.C.J. Koks-Leensen, B.W.M. Schalk, E.J. Bakker–van Gijssel, A. Timen, M.E. Nägele, M. van den Bemd, G.L. Leusink, M. Cuypers, J. Naaldenberg); Siza, Arnhem, the Netherlands (E.J. Bakker-van Gijssel); Maastricht University Medical Center, Maastricht, the Netherlands (G.L. Leusink)

Main Article

Figure 1

Weekly number of COVID-19 infections among persons with intellectual disabilities and the general population, the Netherlands, March 2020–May 2021. Graph shows epidemiologic weeks during 3 pandemic waves in the Netherlands: wave I, March–June 2020; wave II, July 2020–January 2021; and wave III, February–May 2021. The registry included 2,586 persons with intellectual disabilities in long-term care. Scales for the y-axes differ substantially to underscore patterns.

Figure 1. Weekly number of COVID-19 infections among persons with intellectual disabilities and the general population, the Netherlands, March 2020–May 2021. Graph shows epidemiologic weeks during 3 pandemic waves in the Netherlands: wave I, March–June 2020; wave II, July 2020–January 2021; and wave III, February–May 2021. The registry included 2,586 persons with intellectual disabilities in long-term care. Scales for the y-axes differ substantially to underscore patterns.

Main Article

Page created: November 08, 2022
Page updated: December 21, 2022
Page reviewed: December 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external